about
An information system and medical record to support HIV treatment in rural HaitiEvolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatmentGlossary on the World Trade Organisation and public health: part 2Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literatureAntiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011An e-health driven laboratory information system to support HIV treatment in Peru: E-quity for laboratory personnel, health providers and people living with HIV.When to start antiretroviral therapy in resource-limited settings: a human rights analysis.Long-term costs and health impact of continued global fund support for antiretroviral therapyEffectiveness of highly active antiretroviral therapy (HAART) among HIV-infected patients in MexicoImproving access to medicines for neglected tropical diseases in developing countries: lessons from three emerging economies.Survival of AIDS patients in Sao Paulo-Brazil in the pre- and post-HAART eras: a cohort studyCauses of death among people living with AIDS in the pre- and post-HAART Eras in the city of São Paulo, BrazilSimplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in CambodiaCivil society, political mobilization, and the impact of HIV scale-up on health systems in Brazil.Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand.Viewpoint: the Brazilian HIV/AIDS 'success story'--can others do it?Prevalence and characteristics associated with malnutrition at hospitalization among patients with acquired immunodeficiency syndrome in Brazil.Community health advocacyMonotherapy with lopinavir/ritonavir.The impacts of AIDS movements on the policy responses to HIV/AIDS in Brazil and South Africa: a comparative analysis.Retrospective analysis of the clinical behavior of oral hairy leukoplakia in 215 HIV-seropositive patients.Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.Public health and company wealth.The production and R&D structure of the Brazilian pharmaceutical industry: the role of public procurement and public drug production.Commentary: scaling up HIV treatment in resource-limited countries: the challenge of staff shortages.AIDS mortality, "race or color", and social inequality in a context of universal access to highly active antiretroviral therapy (HAART) in Brazil, 1999-2004.Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.Oral health status of people living with HIV/AIDS attending a specialized service in Brazil.HIV/AIDS research in Brazil: the missing piece?Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016Logistics Data Collection and Reporting for Essential Medicines in Developing Countries: A ReviewAccess to generic antiretrovirals: inequality, intellectual property law, and international trade agreementsRetrospective analysis of risk factors and gaps in prevention strategies for mother-to-child HIV transmission in Rio de Janeiro, Brazil
P2860
Q24560061-D339A7BB-5A75-4D1E-A690-30CF4A320EBBQ28471623-C6938405-A07F-4D1C-9551-7CE1E2C62C42Q28756868-B83BC112-AC30-4E30-B162-F8EC0E7FB49AQ30394748-1147869E-4719-4EE2-AA5F-CB7F285CA1E2Q30801599-C2F0F2FD-C15B-4D71-80A1-1DD8089A0F34Q33517901-29C815E3-53A0-41CD-8906-B40AEBC2BEDBQ33548096-7F336F79-4839-42CA-AF18-9A6161B4DBECQ33952153-F112B9E9-5609-4F0C-8CD5-C005C197A150Q34103178-B7816864-C33E-4745-A976-65EAF083BD31Q34184705-D4B0F47C-0197-4C76-8FF1-E9409FF63B9AQ34588088-98F87E3C-E5C0-42E2-957C-8A3A28B627F0Q34681425-A3D6F57E-DDC3-4788-BA28-9F3BCC8C0541Q34730386-58AB9B33-061A-411D-A30A-5A16784737E5Q35169364-D06ECD8B-1DCC-49D7-BD03-955813ACCD33Q35605497-8F50E53A-FC53-46DB-B8FD-C8747768FE0EQ35709575-C2541787-6F8A-4FE1-9E55-FDBCEFF1076DQ36381037-9A885E8A-FE85-4C40-B4C7-8791586F6A22Q36477967-FF8E22F3-4207-4589-99C0-9846E733E0C0Q36802635-9E83E94D-D006-4174-BBB9-7D110A620B3FQ37082149-F0DB65D8-7D12-4D4F-B1D5-BA82793117C2Q39143497-A3441E3E-46E9-4017-B188-583EB3672145Q39206462-B840D8F7-41B0-420D-9C4E-90C45034663CQ41984585-86C9B827-1C0B-4547-83ED-BA066D06F43AQ45371507-BA3FFF28-27DF-4A10-871C-E9E92734D947Q46450763-B6D3C749-16E2-4B52-9B0C-07CBFC64EB55Q50139897-BE1F2417-A3BB-4B4D-99B0-A3AD34F5F598Q53151607-01AF7805-3525-47EF-ADAF-66928D79FD20Q53909853-F81A50A2-F6BB-4CF8-9AD2-C50C70727CD9Q54550218-4E57900A-789B-4CCB-A3A3-4C8DD4F1E0FCQ56448078-AA2EBAD4-F61A-42CF-B998-9E69B23E99B6Q57258595-4BF9989B-FCE8-4DA9-9C3C-821F820388DDQ58393660-89D6E91B-F244-448F-8CD8-9831DB90F723Q58478541-588850D6-A782-40AD-9F35-EF98B5045814Q58755669-5A5CE65C-1E26-4B45-98A6-A6F106CB2A52
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Access to antiretroviral drugs in Brazil.
@en
Access to antiretroviral drugs in Brazil.
@nl
type
label
Access to antiretroviral drugs in Brazil.
@en
Access to antiretroviral drugs in Brazil.
@nl
prefLabel
Access to antiretroviral drugs in Brazil.
@en
Access to antiretroviral drugs in Brazil.
@nl
P1433
P1476
Access to antiretroviral drugs in Brazil.
@en
P2093
Jane Galvão
P304
P356
10.1016/S0140-6736(02)11775-2
P407
P577
2002-12-01T00:00:00Z